Showing results (801-810 of 1,017) with videos related to
Sort By:
Pageof 102
American Journal of Otolaryngology|March 10, 2015
Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrenceG J Petruzzelli, J B Howell, A Pederson, et al.Neurobiology of Disease|September 5, 2024
Slc35a2 mosaic knockout impacts cortical development, dendritic arborisation, and neuronal firingJames Spyrou, Khaing Phyu Aung, Hannah Vanyai, et al.The Journal of Pharmacology and Experimental Therapeutics|February 27, 2023
Exploiting the Receptor-Binding Domains of R-Spondin 1 to Target Leucine-Rich Repeat-Containin G-Coupled Protein Receptor 5-Expressing Stem Cells in Ovarian CancerClara Wong, Maria Carmen Mulero, Erika I Barth, et al.British Journal of Cancer|June 9, 1999
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatinB Cenni, H K Kim, G J Bubley, et al.Investigational New Drugs|December 16, 1998
Phase I and pharmacokinetic study of intraperitoneal topotecanS C Plaxe, R D Christen, J O'Quigley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancerK T Robbins, A M Storniolo, C Kerber, et al.American Journal of Clinical Oncology|February 1, 1995
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinomaE F McClay, P D Braly, S Kirmani, et al.American Journal of Obstetrics and Gynecology|December 17, 2017
A randomized controlled trial of screening and brief interventions for substance misuse in reproductive healthSteve Martino, Steven J Ondersma, Ariadna Forray, et al.The Journal of Arthroplasty|December 7, 2018
Predicting Costs Exceeding Bundled Payment Targets for Total Joint ArthroplastySean P Ryan, Daniel E Goltz, Claire B Howell, et al.Cancer|March 1, 1997
A phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanomaE F McClay, M E McClay, J A Jones, et al.Pageof 102